title: Characteristics and prognosis of primary thyroid non-Hodgkin's lymphoma in Chinese patients.
abstract: OBJECTIVE
  There exists no universally accepted treatment for primary thyroid non-Hodgkin's lymphoma (TNHL) due to the rarity of this entity. The aim of this study is to assess the role of surgery and to explore prognostic factors in Chinese TNHL patients.
  
  
  METHODS
  Patient presentations, pathologies, surgical interventions, multidisciplinary treatment, prognostic factors and the value of fine needle aspiration were analyzed.
  
  
  RESULTS
  Between 1991 and 2007, 40 patients of TNHL were diagnosed. Thirty-eight patients underwent an initial surgical procedure. Further treatments consisted of radiotherapy or chemotherapy alone, and the majority of patients were treated with combined chemo-radiation. After a median follow-up of 95 months, the 5-year overall survival (OS) and relapse-free survival (RFS) was 82% and 74%, respectively. Survival curves showed no significant difference between therapeutic operations when compared with diagnostic operations. A univariate analysis showed both International Prognostic Index (IPI) and staging significantly influenced OS and RFS. In multivariate analysis, IPI was found to be the only prognostic factor.
  
  
  CONCLUSIONS
  Combined chemotherapy and radiotherapy may offer better outcome without the need for extensive resection, and surgery should be reserved to providing tissue for diagnosis. The patients with low-intermediate risk (IPI = 2) or stage IIE need be treated more aggressively.
authors.affiliation: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center (FUSCC), Shanghai, China.
authors.forename: Tuan-Qi
authors.initials: TQ
authors.lastname: Sun
authors.forename: Xiao-Li
authors.initials: XL
authors.lastname: Zhu
authors.forename: Zhuo-Ying
authors.initials: ZY
authors.lastname: Wang
authors.forename: Chao-Fu
authors.initials: CF
authors.lastname: Wang
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Zhou
authors.forename: Qing-Hai
authors.initials: QH
authors.lastname: Ji
authors.forename: Yi
authors.initials: Y
authors.lastname: Wu
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D017024:Chemotherapy, Adjuvant; D002681:China; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D037981:Neck Dissection; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D016019:Survival Analysis; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery*; D013965:Thyroidectomy / Q000379:methods